Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Intravenous Versus Oral Antibiotics for the Prevention of Treatment Failure in Children With Complicated Appendicitis: Has the Abandonment of Peripherally Inserted Catheters Been Justified?

Rangel, Shawn J. MD, MSCE*; Anderson, Brett R. MD, MBA, MS; Srivastava, Rajendu MD, FRCPC, MPH‡,§,¶; Shah, Samir S. MD, MSCE||; Ishimine, Paul MD¶¶; Srinivasan, Mythili MD, PhD**; Bryan, Matthew PhD††,‡‡; Gong, Wu MS††; Hall, Matt PhD§§; Localio, Russell PhD‡‡; Luan, Xianqun MS††; Anandalwar, Seema MD*; Keren, Ron MD, MPH††,‡‡for the Pediatric Research in Inpatient Settings (PRIS) Network

doi: 10.1097/SLA.0000000000001923
ORIGINAL ARTICLES

Objective: To compare treatment failure leading to hospital readmission in children with complicated appendicitis who received oral versus intravenous antibiotics after discharge.

Background: Antibiotics are often employed after discharge to prevent treatment failure in children with complicated appendicitis, although existing studies comparing intravenous and oral antibiotics for this purpose are limited.

Methods: We identified all patients aged 3 to 18 years undergoing appendectomy for complicated appendicitis, who received postdischarge antibiotics at 35 childrens hospitals from 2009 to 2012. Discharge codes were used to identify study subjects from the Pediatric Health Information System database, and chart review confirmed eligibility, treatment assignment, and outcomes. Exposure status was based on outpatient antibiotic therapy, and analysis used optimal and full matching methods to adjust for demographic and clinical characteristics. Treatment failure (defined as an organ-space infection) requiring inpatient readmission was the primary outcome. Secondary outcomes included revisits from any cause to either the inpatient or emergency department setting.

Results: In all, 4579 patients were included (median: 99/hospital), and utilization of intravenous antibiotics after discharge ranged from 0% to 91.7% across hospitals. In the matched analysis, the rate of treatment failure was significantly higher for the intravenous group than the oral group [odds ratio (OR) 1.74, 95% confidence interval (CI) 1.05–2.88; risk difference: 4.0%, 95% CI 0.4–7.6%], as was the rate of all-cause revisits (OR 2.11, 95% CI 1.44–3.11; risk difference: 9.4%, 95% CI 4.7–14.2%). The rate of peripherally inserted central catheter line complications was 3.2% in the intravenous group, and drug reactions were rare in both groups (intravenous: 0.7%, oral: 0.5%).

Conclusions: Compared with oral antibiotics, use of intravenous antibiotics after discharge in children with complicated appendicitis was associated with higher rates of both treatment failure and all-cause hospital revisits.

*Department of Pediatric Surgery, Children's Hospital Boston-Harvard Medical School, Boston, MA

Division of Pediatric Cardiology, Columbia University Medical Center, New York-Presbyterian, Morgan Stanley Children's Hospital, New York, NY

Division of Inpatient Medicine, Department of Pediatrics, University of Utah Health, Sciences Center, Salt Lake City, UT

§Primary Children's Hospital, Intermountain Healthcare, Salt Lake City, UT

Institute for Healthcare Delivery Research, Intermountain Healthcare, Salt Lake City, UT

||Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

**Department of Pediatrics, Washington University School of Medicine, St. Louis, MO

††Division of General Pediatrics, Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA

‡‡Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

§§Children's Hospital Association, Overland Park, KS

¶¶Rady Children's Hospital, San Diego, CA.

Reprints: Shawn J. Rangel, MD, MSCE, Department of Pediatric Surgery, Boston Children's Hospital, 300 Longwood Ave - Fegan 3, Boston, MA 02115. E-mail: shawn.rangel@childrens.harvard.edu.

Source of funding: Research reported in this publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (#4252940000), but had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript.

Conflicts of interest: No conflicts of interest were reported by the study authors.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.